Paolo Morgese is an healthcare investment and market access professional with more than 15 years experience in both assessing and supporting access of innovative healthcare technologies. In 2017, after having worked in the payer, the medical device, the pharma/biotech and in the healthcare investment industries, he founded forethought access – an early-stage market access consulting firm. Paolo’s interests and expertise are in healthcare technology value assessment and maximization; with particular interest in early stages of product development. Paolo is an engaged stakeholder in International, European and EU national policy debates around health technology assessment convergence, access to cell and gene therapies, early dialogue activities, value-based pricing/contracting and other market access related topics. He is the past chair of the European Biotech Industry Association HTA task force, biotech industry representative at the EUnetHTA Joint Action 2 Stakeholder Forum and current EU Director of Market Access and Member Relations at ARM, the Alliance for Regenerative Medicine.
Paolo Morgese holds a BSc in Economics from the University of Siena (Italy) and a MSc in Financial and Business Economics from the University of Essex (UK)
Brigitte Casteels Rappagliosi
Medical Device Consulting
Brigitte Casteels-Rappagliosi is an acknowledged international business leader who combines strong commercial acumen and extensive field experience in Market Access, Funding and Reimbursement, and Public Affairs for Medical Technology, including medical devices and in vitro diagnostics. Brigitte founded BC Consulting and Solutions in 2011 to deliver personalized, inclusive and international consulting services to the innovative medical technology companies that aim to invest and expand their footprint in Europe. Prior to that, Brigitte developed a long-standing career in the medical devices industry, including executive positions in major corporations as well as innovative SMEs.
Thanks to more than 20 years of professional activity, Brigitte engages with relevant public health authorities’ networks and decision makers across Europe, including the European institutions, on critical issues impacting the medical devices industry.
Brigitte has led successful reimbursement strategies introducing new medical devices in several western European markets such as: France, Belgium, Italy, Spain, UK, Netherlands, Germany, Austria, Switzerland and Italy.
Brigitte is a trained pharmacist by the University of Antwerpen – Belgium